New CIT Super Deduction Rules for R&D Expenses in 2026 | China WFOE Guide

For wholly foreign-owned enterprises (WFOEs) operating in China, the research and development (R&D) expense super deduction remains one of the most powerful tax incentives available. Under the 财政部 税务总局 科技部公告2023年第7号 (Ministry of Finance and STA Announcement No. 7 of 2023), the 100% super deduction has been established as a long‑term, indefinite policy—no longer subject to annual renewal. As of 2026, the legal framework remains fully in force, with enhanced compliance requirements around documentation, auxiliary ledgers, and the three‑track R&D expense measurement system (accounting, high‑tech enterprise, and super deduction). For foreign‑invested enterprises engaged in technology development, understanding these 2026 R&D super deduction rules—the expanded activities scope, the negative‑list industries, the treatment of overseas R&D, and the practical steps to document claims—is essential for maximizing tax savings while avoiding audit triggers. This guide provides a comprehensive overview of the current super deduction framework and a step‑by‑step compliance roadmap for WFOEs.

1. Core Super Deduction Rules in 2026

Under the current policy framework, which took effect on January 1, 2023, and continues indefinitely into 2026 and beyond, the R&D expense super deduction operates on a two‑track structure depending on whether the R&D expenditure results in an intangible asset.

For R&D expenses that are expensed (i.e., charged to the current period’s profit and loss without being capitalized), the WFOE may deduct 100% of the actual expense in addition to the regular deduction. For example, if a WFOE incurs RMB 1 million in qualifying R&D expenses, it may deduct RMB 2 million for CIT purposes—the original RMB 1 million plus an additional RMB 1 million super deduction.

For R&D expenses that form intangible assets (e.g., patented technology, software), the super deduction is applied through amortization. The asset’s cost basis is 200% of the actual R&D expenditure, amortized over the asset‘s useful life. For example, if RMB 1 million in R&D expenditure is capitalized as an intangible asset, the amortizable basis is RMB 2 million.

This policy is now a long‑term institutional arrangement, meaning there is no sunset date—WFOEs can rely on its continued availability for multi‑year R&D planning.

2. Applicable Industries – Who Can Benefit (and Who Cannot)

The super deduction is available to enterprises in all industries except those explicitly listed in the negative list. Under 财税〔2015〕119号 (CAI SHUI [2015] No. 119), the following industries are excluded from claiming the R&D expense super deduction:

• Tobacco manufacturing (烟草制造业)
• Accommodation and catering (住宿和餐饮业)
• Wholesale and retail (批发和零售业)
• Real estate (房地产业)
• Leasing and business services (租赁和商务服务业)
• Entertainment (娱乐业)
• Other industries specified by the Ministry of Finance and the State Administration of Taxation

For a WFOE operating in a multiple‑industry group, the determining factor is the primary business. An enterprise is disqualified if its main business (generating more than 50% of total revenue, excluding nontaxable income and investment gains) falls into any of the excluded categories.

A WFOE in a permitted industry (manufacturing, technology, professional services) can claim the benefit as long as it conducts qualifying R&D activities.

3. Qualifying R&D Activities – What Counts

Under the regulations, R&D is defined as: “Activities systematically conducted with clear objectives to acquire new scientific or technical knowledge, creatively apply new scientific or technical knowledge, or substantially improve technologies, products (services), or processes.”

The following activities do NOT qualify for super deduction:

• Routine upgrades – Standard product or service updates without creative new knowledge.
• Direct application of existing research – Using known processes, materials, or products without modification.
• Post‑commercial technical support – After‑sales services for existing products.
• Repeated or simple changes – To existing products, services, processes, or materials.
• Market research and management studies – Surveys, efficiency studies, or management research.
• Routine quality control, testing, or maintenance – Standard industrial process steps.
• Social sciences, arts, or humanities research – Excluded from the super deduction scope.

4. Eligible R&D Expense Categories

The super deduction covers seven specific categories of expenses directly related to qualifying R&D activities:

• Personnel expenses (人员人工费用): Salaries, wages, social insurance contributions (basic pensions, medical, unemployment, work injury, maternity), housing funds, and outsourced R&D personnel costs.
• Direct input expenses (直接投入费用): Raw materials, fuel, power, mold development, non‑capitalized samples, testing fees, and leased equipment costs.
• Depreciation (折旧费用): Depreciation of instruments and equipment used for R&D.
• Intangible asset amortization (无形资产摊销): Amortization of software, patents, and proprietary technologies used in R&D.
• New product/process design fees (新产品设计费): Costs for design, process development, clinical trials, and field testing.
• Other related expenses (其他相关费用): Technical literature, translation, expert consultation, R&D insurance, IP application fees, travel, meetings, and supplementary benefits—limited to 10% of the total qualifying R&D expenses (excluding this category itself).

Each expense must be directly attributable to a specific R&D project and properly documented. Indirect or shared expenses require a reasonable allocation methodology (e.g., time sheets for personnel working on both R&D and production).

5. Overseas R&D: The 80%×2/3 Rule

For WFOEs that commission R&D activities to overseas entities, the super deduction applies under a restricted formula. Under 财税〔2018〕64号 (CAI SHUI [2018] No. 64), overseas R&D expenses are subject to a two‑step limitation:

• 80% inclusion: Only 80% of the actual overseas R&D expenses are eligible for super deduction. For example, if RMB 1 million is paid to an overseas R&D provider, only RMB 800,000 enters the calculation.
• 2/3 of domestic R&D cap: The qualifying overseas R&D amount (after the 80% reduction) must not exceed two‑thirds of the enterprise‘s domestic qualifying R&D expenses.

If domestic R&D expenses are RMB 900,000, the maximum eligible overseas R&D (after 80%) is RMB 600,000 (i.e., 2/3 of RMB 900,000). Any excess cannot be claimed.

Key documentation requirements for overseas R&D claims:

• The overseas R&D contract must be registered with the competent science and technology authority (科技行政主管部门登记).
• For related‑party overseas R&D (e.g., a WFOE‘s foreign parent providing R&D services), the foreign provider must supply a detailed breakdown of project expenses.
• Retain bank payment records and receipts from the overseas provider.
• Maintain an auxiliary ledger for the overseas R&D project.

6. Three‑Tier Measurement System: Accounting vs. High‑Tech vs. Super Deduction

A critical compliance concept for WFOEs is understanding that the measurement of “R&D expenses” differs across three regulatory systems. This distinction is often a source of audit findings:

• Accounting口径 (Accounting measurement – as recorded in financial statements): Used for bookkeeping and financial reporting. This is the broadest definition, including all R&D‑related costs.
• 加计扣除口径 (Super deduction measurement – as defined under CIT rules): Used for claiming the R&D super deduction. This is a subset of the accounting R&D expenses—only those expenses that meet the strict criteria in the tax regulations.
• 高新技术企业口径 (High‑tech enterprise measurement – under the HTA identification framework): Used for applying for or maintaining High‑Tech Enterprise (HTE) status. HTA measurement includes additional items such as non‑R&D technical professionals and has different thresholds for the 60% high‑tech revenue ratio.

The three systems are governed by different regulatory frameworks and serve different purposes. The super deduction claim must be based strictly on the CIT measurement, not the accounting or HTA figures. Using a broader measurement for the super deduction claim is a common error that triggers tax audits. For HTE applicants, the regulations explicitly require that the R&D expense documentation aligns with the specific HTA measurement requirements. The safest approach is to maintain separate auxiliary ledgers for each measurement system.

7. Auxiliary Ledger and Documentation Requirements (2026 Updates)

The “retain documentation for future reference” system applies to R&D super deduction claims. No prior approval is required; WFOEs may self‑assess their eligibility and claim the deduction in their CIT filings. However, all supporting documentation must be retained and made available for tax authority inspection.

The key documentation requirements for 2026 remain consistent with prior rules:

• Each R&D project must have a dedicated auxiliary ledger (辅助账), with detailed records of all eligible expenses.
• For shared resources (e.g., personnel who work on both R&D and production), maintain daily activity logs (工时记录表) that clearly allocate time between R&D and non‑R&D activities. Without these logs, the tax authority may disallow the expense allocation entirely.
• The “研发支出”辅助账汇总表 (Auxiliary Ledger Summary Table) is no longer required to be submitted with the CIT return. It must be retained on file by the enterprise and produced upon request.
• Retain project records, including the R&D project plan, internal approval documents, and progress reports.

For a WFOE with multiple R&D projects in a given year, each project must have its own auxiliary ledger. Commingling expenses across projects without proper allocation is a common audit trigger.

8. Timing of Claim: Prepayment vs. Annual Reconciliation

Under the current policy, WFOEs may claim the R&D super deduction at two prepayment stages during the tax year, in addition to the annual CIT reconciliation:

• July prepayment (2nd quarter): WFOEs may claim the super deduction for R&D expenses incurred during the first half of the tax year when filing the July CIT prepayment.
• October prepayment (3rd quarter): WFOEs may claim the super deduction for R&D expenses incurred during the first three quarters when filing the October CIT prepayment.
• Annual reconciliation (by May 31 of the following year): If not claimed earlier, the super deduction may be claimed in the final annual CIT settlement.

Early claiming improves cash flow, but the WFOE must have accurate R&D expense data at the time of the prepayment filing. If the data is incomplete, it is safer to defer to the annual reconciliation.

9. Practical Compliance Roadmap for WFOEs

To maximize the R&D super deduction benefit while avoiding audit risks, follow this six‑step roadmap:

1. Confirm industry eligibility (Immediate): Verify that your WFOE‘s primary business (more than 50% of revenue, excluding nontaxable income and investment gains) is not in any of the excluded negative‑list industries. For multiple‑industry groups, this requires careful revenue tracking.
2. Identify qualifying R&D projects (Ongoing): At the start of each tax year, define the R&D objectives and expected outcomes. Ensure that the project descriptions do not contain “routine upgrade,” “market research,” or other flagged keywords. For projects that begin mid‑year, document the start date and scope immediately.
3. Implement project‑based expense tracking (Ongoing): For each R&D project, maintain a separate auxiliary ledger (辅助账). Record expenses as they are incurred, not at year‑end. For shared expenses (personnel, equipment), maintain allocation logs (e.g., daily time sheets).
4. Distinguish the three measurement systems (Annually): Prepare separate R&D expense reports for accounting (financial statements), super deduction (CIT filing), and, if applicable, high‑tech enterprise (HTA) purposes. Do not mix the calculations. For HTE applicants, track the HTA‑allowable R&D expenses monthly to ensure the 60% high‑tech revenue ratio is maintained.
5. Prepare overseas R&D documentation (If applicable): For any R&D contracted to overseas entities, ensure the contract is registered with the technology authority, calculate the 80% inclusion amount, and verify that the resulting amount does not exceed 2/3 of domestic R&D expenses. Retain bank payment records and receipt confirmations.
6. File the super deduction claim (By annual CIT deadline May 31): Self‑assess eligibility and file through the e‑Tax Bureau portal. Retain all auxiliary ledgers, project documents, and time allocation records for at least 10 years (the standard CIT documentation retention period). Note that the auxiliary ledger summary table is no longer filed with the return but must be available upon request.

Summary: China’s R&D super deduction—100% for expensed costs and 200% for intangible asset amortization—is now a long‑term policy, fully applicable in 2026 and beyond. The benefit is available to all industries except the negative‑list sectors (tobacco, hospitality, retail, real estate, leasing, and entertainment). Qualifying R&D activities must go beyond routine upgrades, market research, or quality control and be supported by project‑specific auxiliary ledgers and, where applicable, daily time‑allocation logs. Overseas R&D expenses are subject to an 80% inclusion and a 2/3 of domestic R&D cap. A critical compliance nuance is the three‑tier measurement system: accounting R&D expenses, super deduction R&D expenses, and high‑tech enterprise R&D expenses each follow different rules—and mixing the calculations is a common audit trigger. By following the step‑by‑step roadmap, WFOEs can legally maximize their CIT savings while maintaining full audit readiness.